<!DOCTYPE html>
<html lang="en">
	<head>
		<!--Meta tags-->
		<meta charset="UTF-8" />
		<meta name="viewport" content="width=device-width, initial-scale=1.0" />
		<!--Open Graph Tags-->
		<meta property="og:site_name" content="TBFighters" />
		<meta property="og:url" content="https://tbfighters.org" />
		<meta property="og:type" content="website" />
		<meta property="theme-color" content="#D7211E" />
		<!-- Style Tags -->
		<link rel="stylesheet" href="../style.css" />
		<link rel="stylesheet" href="../libs/toastify/toastify.css">
		<link rel="apple-touch-icon" sizes="180x180" href="../img/favicon/apple-touch-icon.png">
		<link rel="icon" type="image/png" sizes="32x32" href="../img/favicon/favicon-32x32.png">
		<link rel="icon" type="image/png" sizes="16x16" href="../img/favicon/favicon-16x16.png">
		<link rel="manifest" href="../img/favicon/site.webmanifest">
		<link rel="icon" type="image/x-icon" href="../img/favicon/favicon.ico">
		<script src="../menu.js" defer></script>
		<script src="../libs/toastify/toastify.js"></script>
		<!-- Variable Tags -->
		<meta name="robots" content="noindex">
		<meta property="og:title" content="Johnson & Johnson Commit to Non-Enforcement of Secondary Patents | TBFighters" />
		<meta property="og:image" content="https://tbfighters.org/img/og-image.jpg" />
		<meta property="og:description" content="Fighting for accessible tuberculosis testing and treatment to save over a million lives a year. Take action with us now." />
		<meta name="description" content="Fighting for accessible tuberculosis testing and treatment to save over a million lives a year. Take action with us now." />

		<title>Johnson & Johnson Commit to Non-Enforcement of Secondary Patents | TBFighters</title>
	</head>
	<body class="news">
		<header id="site-head"><a href="#main" class="skip">Skip to main content</a>
			<div class="wrapper-head">
		
				<div class="page-title">
					<a href="../index.html"><img src="../img/simplified-hourglass.png" alt=""><span
							class="black-highlight">TB</span>FIGHTERS</a>
				</div>
				<a id="hamburger-button" href="#" title="menu"></a>
				<nav class="site-menu">
					<ul class="active">
						<li class="dropdown lined" id="nav-about">
							<div>
								<div class="mobile"></div>
								<a href="../about.html" class="title">About Us</a><button
									aria-label="Open menu About us" class="dropdown-button"><img
										src="../img/icons/chevron-white.svg"
										alt="dropdown arrow"></button>
							</div>
							<ul class="dropdown-content">
								<li><a href="../book-club" class="title">TBReaders Bookclub</a>
								</li>
								<li><a href="../timeline.html" class="title">News & Timeline</a>
								</li>
							</ul>
						</li>
						<li class="non-dropdown lined" id="nav-learn-more"><a class="title"
								href="../resources.html">About TB</a></li>
						<li class="dropdown lined" id="nav-take-action">
							<div>
								<div class="mobile"></div>
								<a class="title" href="../action.html">Take Action</a><button
									aria-label="Open menu Take Action" class="dropdown-button"><img
										src="../img/icons/chevron-white.svg"
										alt="dropdown arrow"></button>
							</div>
							<ul class="dropdown-content">
								<li><a href="../danaher/" class="title">Affordable Testing</a></li>
								<li><a href="../funding-cuts/" class="title">Funding Cuts</a></li>
								<li><a href="../hill-day/" class="title">US Hill Day</a></li>
								<li><a href="../templates/" class="title">Templates</a></li>
							</ul>
						</li>
						<li class="non-dropdown socials" id="nav-socials">
							<p class="smaller socials-wrapper">
								<a href="https://newsletter.tbfighters.org/subscribe" target="_blank"><img
										src="../img/socials/newsletter.svg"
										aria-label="Newsletter" class="social-icon"><img
										src="../img/socials/newsletter-hover.svg"
										class="social-icon-hover"></a>
								<a href="https://bsky.app/profile/tbfighters.org" target="_blank"><img
										src="../img/socials/bsky-nav.svg"
										aria-label="Blue Sky" class="social-icon"><img
										src="../img/socials/bsky-nav-hover.svg"
										class="social-icon-hover"></a>
								<a href="https://www.instagram.com/tbfighters" target="_blank"><img
										src="../img/socials/insta-nav.svg"
										aria-label="Instagram" class="social-icon"><img
										src="../img/socials/insta-nav-hover.svg"
										class="social-icon-hover"></a>
								<a href="https://www.youtube.com/@TB_Fighters" target="_blank"><img
										src="../img/socials/youtube-nav.svg"
										aria-label="Youtube" class="social-icon"><img
										src="../img/socials/youtube-nav-hover.svg"
										class="social-icon-hover"></a>
							</p>
						</li>
					</ul>
				</nav>
		
			</div>
		</header>
		<main id="main">
			<section class="container container-full">
				<div class="wrapper-full">
					<h1 class="break-anywhere">
						Johnson &amp; Johnson Commit to Non-Enforcement of Secondary Patents in low- and middle-income countries
					</h1>
					<p class="news-date"><em>October 3, 2023</em></p>
					<p>
						TBfighters around the world are thrilled at the <a href="https://www.jnj.com/johnson-johnson-confirms-intent-not-to-enforce-patents-for-sirturo-bedaquiline-for-the-treatment-of-multidrug-resistant-tuberculosis-in-134-low-and-middle-income-countries" target="_blank">news</a> that Johnson &amp; Johnson will not enforce secondary patents for SIRTURO® (bedaquiline) in 134 low- and middle-income countries. This builds upon their agreement with the Stop TB Partnership/Global Drug Facility (GDF), which allowed for generic bedaquiline in 44 countries. Johnson &amp; Johnson’s announcement means people with multidrug-resistant tuberculosis (MDR-TB) will be able to access a more affordable bedaquiline-containing treatment regimen regardless of their country’s eligibility or willingness to procure drugs through the GDF.
					</p>
					<p>
						Ending secondary patent enforcement will expand access to generic bedaquiline for countries such as South Africa, Ukraine, and Belarus, all of whom have a high-burden of TB but were excluded from the agreement with the GDF, meaning that until now they faced the continuation of high prices for bedaquiline. This represents a deep commitment to global health from J&J. This change of approach will save many lives, and allow more to avoid life-changing treatment complications, and we are truly thankful.
					</p>
					<p>
						We are very glad to have played a part in this change, building upon and amplifying years of work from TB advocates and organizations, such as <a href="https://msfaccess.org/msf-calls-commitment-pharma-corporation-jj-not-enforce-extended-patents-lifesaving-tb-drug-main" target="_blank">MSF (Doctors Without Borders)</a>, <a href="https://www.pih.org/article/pih-urges-further-steps-ensure-tb-drugs-available-all" target="_blank">Partners in Health</a>, the <a href="https://www.stoptb.org/news/stop-tbs-global-drug-facility-announces-historic-price-reductions-to-55-bedaquiline-life-saving" target="_blank">Stop TB Partnership</a>, the <a href="https://www.treatmentactiongroup.org/" target="_blank">Treatment Action Group</a>, the <a href="https://www.compcom.co.za/" target="_blank">South African Competition Commission</a>, who launched an investigation into J&J’s bedaquiline pricing, and all those involved in the recent UN High Level Meeting on Tuberculosis, including <a href="https://unitaid.org/" target="_blank">UNITAID</a>. We look forward to working in partnership for further progress. Together, we can end TB.
					</p>
				</div>
			</section>
		</main>
		<footer class="site-foot">
				<p class="socials-wrapper-centered socials-wrapper">
					<a href="https://bsky.app/profile/tbfighters.org" target="_blank"><img
						src="../img/socials/bsky.svg" aria-label="Blue Sky" class="social-icon"><img
						src="../img/socials/bsky-hover.svg" class="social-icon-hover"></a>
					<a href="https://x.com/tbfighters" target="_blank">
						<img src="../img/socials/twitter.svg" aria-label="Twitter" class="social-icon">
						<img src="../img/socials/twitter-hover.svg" class="social-icon-hover"></a>
					<a href="https://www.instagram.com/tbfighters" target="_blank">
						<img src="../img/socials/insta.svg" aria-label="Instagram" class="social-icon">
						<img src="../img/socials/insta-hover.svg" class="social-icon-hover"></a>
					<a href="https://www.youtube.com/@TB_Fighters" target="_blank"><img
						src="../img/socials/youtube.svg" aria-label="Youtube" class="social-icon"><img
						src="../img/socials/youtube-hover.svg" class="social-icon-hover"></a>
					<a href="https://www.facebook.com/profile.php?id=61555332203505" target="_blank"><img
						src="../img/socials/facebook.svg" aria-label="Facebook" class="social-icon"><img
						src="../img/socials/facebook-hover.svg" class="social-icon-hover"></a>
				</p>
				<hr style="width: 10%; margin: 0 auto; margin-bottom: 4px;">
				<p>
					&copy; The TBFighters Project | <a href="privacy.html" class="footer-link">Privacy Policy</a>
				</p>
				<p class="too-small">
					
					We lead by following and we act with compassion. Get in touch: contact at tbfighters dot org
				</p>
			</footer>
	</body>
</html>
